事業内容
あなたはここにいる:ホーム > 事業内容 > 薬理薬効学の研究 > 同所性腫瘍移植モデル
Orthotopic cancer models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds.
Orthotopic cancer models
Orthotopic cancer models by Medicilon were developed for use in the efficacy evaluation of novel anticancer compounds.
Cancer Type | Cell Line | Luciferase Cell Line |
Breast carcinoma | MDA-MB-231, HCC1954, HCC70, MDA-MB-361, MCF7, HCC1954, | MDA-MB-231-luc |
Lung cancer | NCI-H1650 | A549-luc, LLC-luc |
Colon carcinoma | HCT-116 | |
Glioblastoma | U87-MG | U87-MG-luc |
Ovary carcinoma | SK-OV-3 | |
Prostate Cancer | PC3 | |
Leukemia | RL, MAVER-1, Karpas299, K562, HL-60 |
Pharmacology Facility & Equipments
SPF Animal Room:
–Animal Storage: IVC System
–Combination of radiation and chemotherapy: RS 2000 Biological Research Irradiator
–In vivo tumor Imaging: IVIS Lumina III In Vivo Imaging System and Luciferase Cell Line
関連研究室